Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 2/20 | 0.68 |
| ▸ | CNR2 | P34972 | 11/20 | 0.64 |
| ▸ | PSEN1 | P49768 | 6/20 | 0.60 |
| ▸ | PSEN2 | P49810 | 6/20 | 0.60 |
| ▸ | APH1B | Q8WW43 | 6/20 | 0.60 |
| ▸ | NCSTN | Q92542 | 6/20 | 0.60 |
| ▸ | APH1A | Q96BI3 | 6/20 | 0.60 |
| ▸ | PSENEN | Q9NZ42 | 6/20 | 0.60 |
| ▸ | RORA | P35398 | 2/20 | 0.56 |
| ▸ | RORC | P51449 | 2/20 | 0.56 |
| ▸ | RORB | Q92753 | 2/20 | 0.56 |
| ▸ | CNR1 | P21554 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28305156 | 1.00 | PGR (0.68) | PGRCNR2PSEN1PSEN2APH1B | |
| SCHEMBL28304215 | 1.00 | PGR (0.68) | PGRCNR2PSEN1PSEN2APH1B | |
| SCHEMBL28304199 | 1.00 | PGR (0.68) | PGRCNR2PSEN1PSEN2APH1B | |
| SCHEMBL5795461 | 0.99 | PGR (0.70) | PGRCNR2PSEN1PSEN2APH1B | |
| SCHEMBL5514950 | 0.92 | PSEN1 (0.60) | PGRCNR2PSEN1PSEN2APH1B | |
| SCHEMBL5807330 | 0.88 | PGR (0.63) | PGRCNR2PSEN1PSEN2APH1B | |
| SCHEMBL5527461 | 0.84 | PSEN1 (0.60) | PGRCNR2PSEN1PSEN2APH1B | |
| SCHEMBL551644 | 0.84 | PSEN1 (0.62) | PGRCNR2PSEN1PSEN2APH1B | |
| SCHEMBL9976723 | 0.84 | PSEN1 (0.62) | PGRCNR2PSEN1PSEN2APH1B | |
| SCHEMBL9905344 | 0.84 | PSEN1 (0.62) | PGRCNR2PSEN1PSEN2APH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100204356-A1 | POLYURETHANES, POLYUREAS, AND PROCESS FOR THEIR PRODUCTION | KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) | 2010-08-12 | — | — | US | disclosed |
| CN-101802045-A | Polyurethane and polyurea, and method for producing the same | TOYOTA JIDOSHOKKI KK | 2010-08-11 | — | — | CN | disclosed |
| EP-2192137-A1 | POLYURETHANE AND POLYUREA, AND METHOD FOR PRODUCING THE SAME | Kabushiki Kaisha Toyota Jidoshokki (JP) | 2010-06-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204356-A1 | POLYURETHANES, POLYUREAS, AND PROCESS FOR THEIR PRODUCTION | PUF60, PDCD2L, UROD | PGR 922/4885CNR2 3027/4885PSEN1 1689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.